Synthesis of Novel Fatty Substituted 4-methyl-2HChromen-2-one via Cross Metathesis

A series of novel fatty substituted 4-methyl-2H-chromen-2-one (coumarins) were synthesized by employing cross metathesis, a key step in the synthesis. The antioxidant activities of the title compounds were compared with the commercial antioxidants, namely butylated hydroxy toluene (BHT) and α-tocoph...

Full description

Saved in:
Bibliographic Details
Published inJournal of oleo science Vol. 65; no. 12; p. 1023
Main Authors Yelchuri, Vyshnavi, R.B.N. Prasad, Mallampalli S.L. Karuna, Poornachandra, Y, Chityal Ganesh Kumar
Format Journal Article
LanguageEnglish
Published Tokyo Japan Science and Technology Agency 01.12.2016
Subjects
Anticancer properties
Antioxidants
Berries
Breast cancer
Cancer
Fatty acids
Formulations
Metathesis
Prostate cancer
Substitutes
Synthesis
Tocopherol
Toluene
Online AccessGet full text

Cover

More Information
Summary:A series of novel fatty substituted 4-methyl-2H-chromen-2-one (coumarins) were synthesized by employing cross metathesis, a key step in the synthesis. The antioxidant activities of the title compounds were compared with the commercial antioxidants, namely butylated hydroxy toluene (BHT) and α-tocopherol, glycosidic and other substituted 4-methyl-2H-chromen-2-ones. Among the different 4-methyl-2H-chromen-2-ones, the glycosidic substituted 4-methyl-2H-chromen-2-ones was excellent, while those with aliphatic fatty acid chain and hydroxyl substitutents were good. Among the substituted 4-methyl-2H-chromen-2-ones, glycosidic, hydroxyl and cyano containing 4-methyl-2H-chromen-2-ones exhibited good, while fatty substituted exhibited moderate anticancer activities against the four different cancer cell lines tested, namely DU145 (Prostate carcinoma cancer cell), HepG2 (Hepato cellular carcinoma cancer cell), SKOV3 (Ovarian cancer cell) and MDA-MB 231 (Human breast cancer cell). The study reveals that these substituted coumarins can be potential candidates in a number of food and pharmaceutical formulations.
ISSN:1345-8957
1347-3352